![](/img/cover-not-exists.png)
Two dose-ranging studies with PF-04937319, a systemic partial activator of glucokinase, as add-on therapy to metformin in adults with type 2 diabetes
Amin, N. B., Aggarwal, N., Pall, D., Paragh, G., Denney, W. S., Le, V., Riggs, M., Calle, R. A.Volume:
17
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12474
Date:
August, 2015
File:
PDF, 235 KB
english, 2015